BLM and Miyoshi myopathy: Intriguingly, sensitivity to ML216 did not correlate with the levels of expression of any tested RECQ helicase (BLM, RECQ1, RECQL5, and WRN), the cell lines’ basal DDR activation, their MM molecular subgroup or mutations in several oncogenes (Figure 3).